Spectrum Pharma (SPPI) Tops Q3 EPS by 5c

Spectrum Pharma (NASDAQ: SPPI) reported Q3 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.56 million versus the consensus estimate of $24.93 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance